Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication

Area of Science:

• Endocrinology
• Vascular Medicine
• Diabetology

Background:

• Diabetic muscle infarction (DMI) is a rare, debilitating complication of diabetes mellitus, often associated with microvascular issues.
• Current understanding of DMI's incidence, prevalence, and pathogenesis, particularly its microangiopathic basis, remains limited.
• There is a lack of established diagnostic criteria and standardized treatment protocols for DMI.

Observation:

• Patients with DMI presenting with lower extremity mass and pain were studied.
• The study involved initiating a treatment regimen of low-dose acetylsalicylic acid, strict bed rest, and diligent outpatient follow-up.
• Treatment duration ranged from 2 to 17 weeks.

Findings:

• The conservative management approach led to significant reduction in the size of the lower extremity mass.
• Complete resolution of pain associated with DMI was observed in all patients.
• This non-invasive strategy proved effective without the need for muscle biopsy.

Implications:

• This study suggests a viable, conservative treatment pathway for diabetic muscle infarction.
• Early intervention with low-dose aspirin and supportive care may prevent the need for more aggressive or invasive treatments.
• Further research into DMI's pathogenesis is warranted, but this offers immediate clinical guidance.